Boehringer Ingelheim Vetmedica wins approval for vaccine mixing

Boehringer Ingelheim Vetmedica has been granted EU approval for two of its pig vaccine products to be mixed and administered in a single injection.

The European Commission has ratified the company's label claim for the mixing of the mycoplasma vaccine Ingelvac MycoFLEX with the porcine circovirus treatment Ingelvac CircoFLEX.

It follows the regulator's approval of a corresponding Ingelvac CircoFLEX mixing claim in July 2010 and allows the firm to market the drugs as combinable standalone products under the brand name FLEXcombo.

According to the manufacturer, this will allow farmers to protect animals against two of the most common porcine illnesses using only one injection, rather than up to four.

This will be cheaper for business owners, less traumatic for pigs and will also minimise the risk of pathogen transfer via injection needles.

Last month, Boehringer Ingelheim Vetmedica launched Buscopan 20mg/ml, a new antispasmodic treatment that addresses a number of conditions affecting horses and calves.